Total Return Level Chart

View Total Return Level for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Return Level Chart
Start Trial

Historical Total Return Level Data

View and export this data back to 2014. Start Trial.
Date Value
September 16, 2026 10.29
September 15, 2026 10.44
September 14, 2026 10.44
September 11, 2026 10.50
September 10, 2026 10.50
September 09, 2026 10.48
September 08, 2026 10.81
September 04, 2026 11.34
September 03, 2026 11.34
September 02, 2026 11.44
September 01, 2026 11.44
August 31, 2026 11.22
August 28, 2026 10.93
August 27, 2026 11.04
August 26, 2026 11.28
August 25, 2026 11.28
August 24, 2026 11.04
August 21, 2026 10.88
August 20, 2026 9.955
August 19, 2026 9.98
August 18, 2026 9.732
August 17, 2026 9.64
August 14, 2026 9.542
August 13, 2026 9.32
August 12, 2026 9.245
Date Value
August 11, 2026 9.03
August 10, 2026 9.03
August 07, 2026 9.09
August 06, 2026 9.18
August 05, 2026 9.18
August 04, 2026 9.18
August 03, 2026 9.192
July 31, 2026 9.12
July 30, 2026 9.05
July 29, 2026 9.00
July 28, 2026 9.00
July 27, 2026 8.813
July 24, 2026 8.76
July 23, 2026 8.91
July 22, 2026 9.201
July 21, 2026 9.201
July 20, 2026 9.255
July 17, 2026 9.355
July 16, 2026 9.485
July 15, 2026 9.33
July 14, 2026 9.28
July 13, 2026 9.14
July 10, 2026 9.30
July 09, 2026 9.411
July 08, 2026 9.52

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Evaxion AS 3.03
Genmab A/S 34.40
Ascendis Pharma A/S 247.69
Zealand Pharma A/S 43.00
Agenus, Inc. 7.21